DrugPatentWatch Database Preview
Celltrion Company Profile
» See Plans and Pricing
What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?
CELLTRION has nineteen approved drugs.
Summary for Celltrion
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 19 |
| Patent Litigation for Celltrion: | See patent lawsuits for Celltrion |
| PTAB Cases with Celltrion as petitioner: | See PTAB cases with Celltrion as petitioner |
Drugs and US Patents for Celltrion
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celltrion | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078982-002 | Jan 27, 2009 | DISCN | No | No | Start Trial | Start Trial | |||||
| Celltrion | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 090367-003 | Jun 20, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Celltrion | RISPERIDONE | risperidone | TABLET;ORAL | 078871-003 | Oct 9, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
